New MFS-DLPSO-XGBoost AI model achieves 80% precision in cardiovascular risk assessment, endorsed by leading medical organizations as clinical trials show 41% reduction in missed diagnoses. A novel AI...
your path to beautiful life
New MFS-DLPSO-XGBoost AI model achieves 80% precision in cardiovascular risk assessment, endorsed by leading medical organizations as clinical trials show 41% reduction in missed diagnoses. A novel AI...